Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.
Lancet Oncol
; 18(1): 75-87, 2017 01.
Article
in En
| MEDLINE
| ID: mdl-27908594
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Peritoneal Neoplasms
/
Platinum
/
Neoplasms, Glandular and Epithelial
/
Drug Resistance, Neoplasm
/
Fallopian Tube Neoplasms
/
Indoles
/
Neoplasm Recurrence, Local
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Lancet Oncol
Journal subject:
NEOPLASIAS
Year:
2017
Document type:
Article
Country of publication: